Stocktoria

GALECTIN THERAPEUTICS INC GALT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2002-09-04 · LEI

GALECTIN THERAPEUTICS INC statistics & valuation

Market cap$328.6M
Return on capital-174.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-208.30% -268.60% -30.30% -104.40% -3418.50% 2016201720182019202020212022202320242025
Shares outstanding
32.9M 35.8M 41.2M 56.9M 57.1M 59.3M 59.4M 61.9M 63.2M 65.2M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-135.70% -390.20% -154.30% -27.40% -79.30% -73.00% -182.20% -145.60% -268.90% -157.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.41 -$0.52 -$0.65 -$0.74 -$0.76 -$0.48 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-157.9%-268.9%-145.6%-182.2%-73.0%-79.3%-27.4%-154.3%-390.2%-135.7%
Return on equity24.1%44.9%66.3%114.3%-3418.5%-104.4%-30.3%-268.6%3063.2%-208.3%
Current ratio2.420.491.771.584.635.4617.104.191.294.18

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.